ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

REDUCE LAP-HF RANDOMIZED TRIAL I

ClinicalTrials.gov ID: NCT02600234

Public ClinicalTrials.gov record NCT02600234. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure

Study identification

NCT ID
NCT02600234
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Corvia Medical
Industry
Enrollment
44 participants

Conditions and interventions

Conditions

Interventions

  • Inter-Atrial Shunt Device Device
  • Intracardiac Echo Other

Device · Other

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2015
Primary completion
Nov 30, 2016
Completion
Jul 31, 2026
Last update posted
Mar 9, 2023

2015 – 2026

United States locations

U.S. sites
17
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
University of Arizona College of Medicine Tucson Arizona 85724
Yale University New Haven Connecticut 06510
Northwestern University Chicago Illinois 60611
Evanston Northshore Healthcare Evanston Illinois 60201
Cardiovascular Institute of the South Houma Louisiana
Ochsner Medical Center New Orleans Louisiana 70121
Massachusetts General Hospital Boston Massachusetts
University of Michigan Health System Ann Arbor Michigan 41809
Mayo Clinic Rochester Minnesota 55905
Columbia University Medical Center/NewYork Presbyterian Hospital New York New York
Mt. Sinai Hospital New York New York
New York University New York New York
Wake Forest Winston-Salem North Carolina
Ohio Health Columbus Ohio
Ohio State University College of Medicine Columbus Ohio
University of Pennsylvania Philadelphia Pennsylvania
Medical University of South Carolina Charleston South Carolina

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02600234, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 9, 2023 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02600234 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →